HPV vaccine costs ‘too high’ for developing countries – International Federation of Gynecology and Obstetrics

HPV vaccine costs 'too high' for developing countries
International Federation of Gynecology and Obstetrics
Pharmaceutical companies Merck and GlaxoSmithKline have negotiated a rate of $4.50 per dose to supply HPV vaccines to developing countries, a cost described by campaigners as "unjustifiably high". Medecins Sans Frontiers (MSF) said the Gavi Alliance,

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *